COVID-19 and risk of cardiomyocyte injury: The prevailing scenario. Current Medical and Drug Research, [S. l.], v. 5, n. 1, p. 1–8, 2021. Disponível em: https://cmdrj.com/index.php/cmdrj/article/view/46. Acesso em: 21 oct. 2026.